Text Messaging to Reduce Alcohol Relapse in Liver Transplant Patients
1 other identifier
interventional
15
1 country
1
Brief Summary
This is a research study of a text-messaging intervention to reduce alcohol relapse risk in pre-transplant liver transplantation patients. This study is an 8-week, randomized controlled pilot trial to investigate the feasibility and acceptability of a text-messaging intervention for alcohol relapse prevention and stress reduction in 20 liver transplant patients with alcohol-related liver disease. The goals of the study are (1) to develop a mobile, SMS-based stress reduction and alcohol use intervention for pre- liver transplant patients with alcohol-related liver disease (ALD) and (2) to evaluate the feasibility and acceptability of the mobile intervention and its effect on rates of alcohol consumption compared to a Standard Care condition in a liver transplantation center.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 22, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 25, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 6, 2014
CompletedFirst Submitted
Initial submission to the registry
December 13, 2017
CompletedFirst Posted
Study publicly available on registry
January 18, 2018
CompletedJanuary 18, 2018
January 1, 2018
1 year
December 13, 2017
January 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Intervention Feasibility Evaluation
Patterns of text message usage
8 weeks
Alcohol Abstinence Rates
Biologically confirmed (EtG) rates of abstinence from alcohol
8 Weeks
Secondary Outcomes (2)
Subjective Alcohol Abstinence Rates
8 Weeks
Stress Ratings
8 Weeks
Study Arms (2)
Text Message (TM)
EXPERIMENTALParticipants will receive daily text messages and all elements of standard care. They received 3 text messages per day for the first four weeks of the study and 3 messages per week for the last four weeks. Key domains of message topics were chosen based on the content of evidence-based, relapse prevention treatment. Daily messages determined current level of functioning and provide intervention messages in response. Text messages will be sent via Google Voice on a research computer. Participants will respond to the text messages either with a specified response (e.g. YES/NO) or a generic response (e.g. "1"). Some messages will ask for a specific reply in response to a question. Based on the participant's response (e.g. "high," "med," "low"), the research assistant will respond with a text message tailored to the participant's message. All text messages will be sent to the HIC in an amendment to this protocol for approval.
Standard Care (SC)
NO INTERVENTIONParticipants will receive only standard care provided by the liver transplantation team. No additional behavioral or psychosocial interventions will be provided. All aspects of care received by SC participants will also provided to the TM condition participants. Medical care will be managed by medical specialty providers. SC condition participants will receive behavioral treatment within the liver transplantation clinic by psychology fellows and/or psychologists/psychiatrists. Treatment schedules and session topics will be determined by individual providers, per usual practice. These participants will receive only study-specific assessments. Participants in this condition will complete assessments at baseline, 4-weeks and 8-weeks that measure self- reported substance use, stress, and coping skills. At each in-person assessment, participants will provide urine for EtG analysis and will be compensated.
Interventions
In addition to the SC interventions, participants in the Text Message condition received text messages. Participants received 3 text messages per day for the first four weeks of the study and 3 messages per week for the last four weeks. Participants will receive messages targeting known predictors of alcohol abstinence and relapse, including (1) craving, (2) identification of high-risk situations, (3) identification of triggers, (4) stress level, (5) coping skills, and (5) quality of life. The text messages will include motivational messages and behavior-change techniques (e.g. coping with cravings and urges to drink, trigger identification, high-risk situation identification). Messages will encourage participants to continue with sobriety and focus on the success they have achieved so far.
Eligibility Criteria
You may qualify if:
- at least 18 years of age;
- diagnosis of alcohol-related liver disease;
- currently in evaluation for UNOS listing as a liver transplant candidate;
- last reported use of any alcohol within the past 1 year;
- willingness to receive and respond to multiple text messages per day.
You may not qualify if:
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
Study Sites (1)
Yale Transplantation Center/Yale-New Haven Hospital
New Haven, Connecticut, 06510, United States
Related Publications (5)
Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, Rodgers A, Cairns J, Kenward MG, Roberts I. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet. 2011 Jul 2;378(9785):49-55. doi: 10.1016/S0140-6736(11)60701-0.
PMID: 21722952BACKGROUNDWeitzel JA, Bernhardt JM, Usdan S, Mays D, Glanz K. Using wireless handheld computers and tailored text messaging to reduce negative consequences of drinking alcohol. J Stud Alcohol Drugs. 2007 Jul;68(4):534-7. doi: 10.15288/jsad.2007.68.534.
PMID: 17568957BACKGROUNDWebb MS, Hendricks PS, Brandon TH. Expectancy priming of smoking cessation messages enhances the placebo effect of tailored interventions. Health Psychol. 2007 Sep;26(5):598-609. doi: 10.1037/0278-6133.26.5.598.
PMID: 17845111BACKGROUNDPfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nussler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 2007 Feb;13(2):197-205. doi: 10.1002/lt.20934.
PMID: 17205563BACKGROUNDHeron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010 Feb;15(Pt 1):1-39. doi: 10.1348/135910709X466063. Epub 2009 Jul 28.
PMID: 19646331BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin Toll, PhD
Medical University of South Carolina
- STUDY DIRECTOR
Kelly S DeMartini, PhD
Yale Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Masking Details
- All clinical members of the liver transplantation service will be blind to the results of self-report data collected during the study and to urine toxicology results. The PI and Co-I, who also serves as the Project Manager, will not be blind to participant condition. The Research Assistant will not be blind to the participant condition after delivery of the study-provided cell phone to participants randomized to the Text Message condition.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2017
First Posted
January 18, 2018
Study Start
March 22, 2013
Primary Completion
March 25, 2014
Study Completion
May 6, 2014
Last Updated
January 18, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share
Because the sample is so small, was collected at a very specific site with a specific sample, it could be possible for patients to be identified. Therefore, we have are not including data sharing.